Research ArticleOriginal Research

Having a Primary Care Provider is the Strongest Predictor of Successful Follow-up of Participants in a Clinical Trial

Samuel H. Friedman, Chinazo O. Cunningham, Juan Lin, Linda B. Haramati and Jeffrey M. Levsky
The Journal of the American Board of Family Medicine May 2020, 33 (3) 431-439; DOI: https://doi.org/10.3122/jabfm.2020.03.190018

References

  1. 1.↵
    1. Lord SJ,
    2. Irwig L,
    3. Simes RJ
    . When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials? Ann Intern Med 2006;144:850–5.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Lauer MS
    . Comparative effectiveness research: the view from the NHLBI. J Am Coll Cardiol 2009;53:1084–6.
    OpenUrlFREE Full Text
  3. 3.↵
    1. Akl EA,
    2. Briel M,
    3. You JJ,
    4. et al
    . Potential impact on estimated treatment effects of information lost to follow-up in randomised controlled trials (LOST-IT): systematic review. BMJ 2012;344:e2809–e2809.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Altman DG
    . Missing outcomes in randomized trials: addressing the dilemma. Open Med 2009;3:e51–3.
    OpenUrlPubMed
  5. 5.↵
    1. Fleming TR
    . Addressing missing data in clinical trials. Ann Intern Med 2011;154:113–7.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Bower P,
    2. Brueton V,
    3. Gamble C,
    4. et al
    . Interventions to improve recruitment and retention in clinical trials: a survey and workshop to assess current practice and future priorities. Trials 2014;15:399.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Coakley M,
    2. Fadiran EO,
    3. Parrish LJ,
    4. Griffith RA,
    5. Weiss E,
    6. Carter C
    . Dialogues on diversifying clinical trials: successful strategies for engaging women and minorities in clinical trials. J Womens Health (Larchmt) 2012;21:713–6.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Zhang T,
    2. Tsang W,
    3. Wijeysundera HC,
    4. Ko DT
    . Reporting and representation of ethnic minorities in cardiovascular trials: a systematic review. Am Heart J 2013;166:52–7.
    OpenUrlPubMed
  9. 9.↵
    1. Paskett ED,
    2. Reeves KW,
    3. McLaughlin JM,
    4. et al
    . Recruitment of minority and underserved populations in the United States: the Centers for Population Health and Health Disparities experience. Contemp Clin Trials 2008;29:847–61.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Davis AM,
    2. Vinci LM,
    3. Okwuosa TM,
    4. Chase AR,
    5. Huang ES
    . Cardiovascular health disparities: a systematic review of health care interventions. Med Care Res Rev 2007;64:29S–100S.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Pilote L,
    2. Dasgupta K,
    3. Guru V,
    4. et al
    . A comprehensive view of sex-specific issues related to cardiovascular disease. CMAJ 2007;176:S1–44.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Harris DJ,
    2. Douglas PS
    . Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute. N Engl J Med 2000;343:475–80.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Ghare M,
    2. Chandrasekhar J,
    3. Mehran R,
    4. et al
    . Sex disparities in cardiovascular device evaluations: strategies for recruitment and retention of female patients in clinical device trials. JACC Cardiovasc Interv 2019;12:301–8.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    National Institutes of Health. Inclusion of women and minorities as participants in research involving human subjects. Available from: https://grants.nih.gov/grants/funding/women_min/women_min.htm.
  15. 15.↵
    1. Warner ET,
    2. Glasgow RE,
    3. Emmons KM,
    4. et al
    . Recruitment and retention of participants in a pragmatic randomized intervention trial at three community health clinics: results and lessons learned. BMC Public Health 2013;13:192.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Senturia YD,
    2. McNiff Mortimer K,
    3. Baker D,
    4. et al
    . Successful techniques for retention of study participants in an inner-city population. Control Clin Trials 1998;19:544–54.
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Nicholson LM,
    2. Schwirian PM,
    3. Klein EG,
    4. et al
    . Recruitment and retention strategies in longitudinal clinical studies with low-income populations. Contemp Clin Trials 2011;32:353–62.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Yancey AK,
    2. Ortega AN,
    3. Kumanyika SK
    . Effective recruitment and retention of minority research participants. Annu Rev Public Health 2006;27:1–28.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Levsky JM,
    2. Travin MI,
    3. Spevack DM,
    4. et al
    . Rationale and design of a randomized controlled trial comparing stress myocardial perfusion imaging with coronary CT angiography as the initial imaging study for intermediate-risk patients admitted with chest pain. J Cardiovasc Comput Tomogr 2009;3:264–71.
    OpenUrlPubMed
  20. 20.↵
    1. Levsky JM,
    2. Spevack DM,
    3. Travin MI,
    4. et al
    . Coronary computed tomography versus radionuclide myocardial perfusion imaging in chest pain patients admitted to telemetry: a randomized, controlled trial. Ann Intern Med 2015;163:174–83.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Bazemore A,
    2. Petterson S,
    3. Peterson L,
    4. et al
    . Higher primary care physician continuity is associated with lower costs and hospitalizations. Ann Fam Med 2018;16:492–7.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Gadegbeku CA,
    2. Stillman PK,
    3. Huffman MD,
    4. Jackson JS,
    5. Kusek JW,
    6. Jamerson KA
    . Factors associated with enrollment of african americans into a clinical trial: results from the african american study of kidney disease and hypertension. Contemp Clin Trials 2008;29:837–42.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    1. Janson SL,
    2. Alloto ME,
    3. Boushey HA
    ; Asthma Clinical Trials Network. Attrition and retention of ethnically diverse subjects in a multicenter randomized controlled research trial. Control Clin Trials 2001;22:236S–43S.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Bertakis KD,
    2. Azari R,
    3. Helms L,
    4. Callahan E,
    5. Robbins J
    . Gender differences in the utilization of health care services. J Fam Pract 2000;49:147–52.
    OpenUrlPubMedWeb of Science
  25. 25.↵
    1. Nabil-Khorazaty MN,
    2. Johnson AA,
    3. Kiely M,
    4. et al
    . Recruitment and retention of low-income minority women in a behavioral intervention to reduce smoking, depression, and intimate partner violence during pregnancy. BMC Public Health 2007;7:233.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Kearney A,
    2. Daykin A,
    3. Shaw ARG,
    4. et al
    . Identifying research priorities for effective retention strategies in clinical trials. Trials 2017;18:406.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Glassman AB,
    2. Stockdale CR,
    3. et al
    . Effect of telephone calls from a centralized coordinating center on participant retention in a randomized clinical trial. Clin Trials. In press.
  28. 28.
    1. Brunsdon D,
    2. Biesty L,
    3. Brocklehurst P,
    4. et al
    . What are the most important unanswered research questions in trial retention? A James Lind Alliance Priority Setting Partnership: the PRioRiTy II (Prioritising Retention in Randomised Trials) study. Trials 2019;20:593.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords